DSS, INC. sold 9.7% of their position (5.70K shares) of IMPACT BIOMEDICAL INC. on the open market
Open‑market sale worth $17.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 11/22/2024ACC: 0001493152-24-047410
-5.70K
Net shares
Net seller
$17.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
5.70K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−500.00
Price / share
$2.76
Trade value
$1.38K
% of position
0.9%
11/12/2024
58.80K→58.30K
Common Stock
Indirect
Shares
−200.00
Price / share
$2.80
Trade value
$560.00
% of position
0.3%
11/13/2024
58.30K→58.10K
Common Stock
Indirect
Shares
−5K
Price / share
$3.02
Trade value
$15.09K
% of position
8.6%
11/18/2024
58.10K→53.10K
Total
Net shares
−5.70K
Net value
-$17.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/12/2024 | S · Sale | −500.00 | $2.76 | $1.38K | 0.9% | 58.80K | 58.30K |
| Common Stock Indirect | 11/13/2024 | S · Sale | −200.00 | $2.80 | $560.00 | 0.3% | 58.30K | 58.10K |
| Common Stock Indirect | 11/18/2024 | S · Sale | −5K | $3.02 | $15.09K | 8.6% | 58.10K | 53.10K |
| Total | −5.70K | -$17.02K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned166.60K
Common Stock
IndirectShares owned166.60K
Common Stock
IndirectShares owned1.35M
Total
1.68M indirect1.68M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 166.60K | Indirect |
| Common Stock | 166.60K | Indirect |
| Common Stock | 1.35M | Indirect |
| Total | 1.68M | 1.68M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported